"And yet here we are eargerly anticipating the end of the trial, an end which will not come until an unspecified number of people suffer such an event."

A great reminder GAC. We should be thankful for all participants in clinical trials, especially those who suffer in the journey to drug approval. However the sooner the placebo controlled BETonMACE trial is completed (hopefully with positive results) the sooner the FDA/EMA can approve apabetalone for use to start decreasing these events going forward and potentially become the new standard of care. 

BearDownAZ